NCT03203408View on ClinicalTrials.gov

Efficacy of OSTENIL PLUS (Hyaluronic Acid) Versus SYNVISC-ONE in Patients With Tibiofemoral Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

June 21, 2011

Primary Completion Date

November 22, 2012

Study Completion Date

November 22, 2012

Conditions
Knee Osteoarthritis
Interventions
DEVICE

OSTENIL PLUS

Injection into the joint cavity of the most painful knee

DEVICE

SYNVISC-ONE

Injection into the joint cavity of the most painful knee

All Listed Sponsors
lead

TRB Chemedica

INDUSTRY

NCT03203408 - Efficacy of OSTENIL PLUS (Hyaluronic Acid) Versus SYNVISC-ONE in Patients With Tibiofemoral Osteoarthritis | Biotech Hunter | Biotech Hunter